PainRelief.com: What are the main findings?
Response: After treatment, all study participants experienced a statistically significant reduction in pain and WOMAC scores. The mean VAS baseline of 8.58 decreased to 5.02, while the mean WOMAC score decreased from 66.6 at baseline to 41. There was no specific patient characteristic, clinical history, or degree of osteoarthritis that predicted degree pain relief. The greatest increase in functionality and decrease in pain was recorded for patients 50 and older compared to younger participants.
PainRelief.com: What should readers take away from your report?
Response: Genicular nerve RFA is a safe, effective and minimally invasive procedure that provides an opportunity for patients to regain a higher quality of life by decreasing the pain that they experience on a daily basis.
PainRelief.com: What recommendations do you have for future research as a result of this study?
Response: We are interested in continued research into RFA, including deeper dives into what other factors could predict how well it works in different patients and how long the pain reduction may last. Additionally, the same treatment is used for the shoulder, hips, and sacroiliac joints, so we would like to look further into those and determine possible variations.
Disclosures: Dr. Smirniotopoulos is a consultant for Zimvie, Boston Scientific, and Balt.
Genicular nerve radiofrequency ablation: Is there a predictor of outcomes?
Society of Interventional Radiology’s 2023 Annual Scientific Meeting
The information on PainRelief.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.